The call for 50 Funded Observerships will close on 16 October 2024! ESCMID observerships provide participants with a fantastic opportunity to gain experience and exchange knowledge with colleagues across the fields of CM & ID. Choose and contact your target institution among 123 ESCMID Collaborative Centres.

Science & Research

The Study Group Collaboration Grant is a larger-scale grant for innovative research projects in clinical microbiology and infectious diseases organised by an experienced PI with the support of at least three ESCMID SGs. Designed for a maximum duration of two years, your project should be of high quality, with a focus on innovation and networking.

The current epidemiological situation regarding mpox, a zoonotic viral disease caused by the monkeypox virus (MPXV), is complex. Multiple simultaneous epidemics involving distinct clades of MPXV are occurring across different geographic regions, each affecting distinct at-risk populations.

Check out the newly published commentary by the Emerging Infections Subcommittee.

Education

Our "Challenges in Clinical Parasitology" course equips clinical microbiologists and infectious disease specialists with essential skills to recognise and diagnose these conditions early, preventing severe outcomes. Enhance your expertise and play a pivotal role in combating these persistent global health challenges.

This onsite workshop offers a highly interactive learning experience designed to equip healthcare professionals with the practical skills to implement successful behaviour change interventions. Through collaborative group discussions and case-based exercises, delegates will develop targeted strategies to reduce hospital-acquired infections and mitigate antimicrobial resistance.

This course is part of the ESCMID AMS Certificate Programme.

Guidelines & Journals

• Mpox rapid guidelines (NEW): last day to apply to the call for panel members
  
  
• The draft document "Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2024 Guideline on Management and Treatment of Complicated Urinary Tract Infections" is now available for public consultation

Carbapenemase producers are a nightmare for clinicians. In this episode of Communicable, hosts Angela Huttner and Thomas Tängdén sit down with Dr. David Paterson (National University of Singapore) and Dr. Souha Kanj (American University of Beirut Medical Center, Lebanon), two ID physicians from regions where carbapenem-resistant Enterobacteriaceae or CRE, and carbapenem-resistant Acinetobacter are widespread.

The episode begins with the history and emergence of CRE and reviews current epidemiology, diagnosis (including the Ambler classification of β-lactamases) and treatment options.

Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs

Establishing a dedicated UTI clinic: Challenges and a guide to success

A Marburg virus disease (MVD) outbreak is currently evolving in Rwanda, East Africa – as of 7 October, over 40 confirmed MVD cases have been reported, mainly in healthcare facilities in Kigali, with many healthcare workers affected. For more information, visit the WHO website.